Stewart Parker Resigns from Board of Targeted Genetics, Susan Robinson Takes Her Spot
Luke Timmerman11/17/08
H. Stewart Parker has resigned from the board of Targeted Genetics, a week after she stepped down as president and CEO. The Seattle-based biotech company (NASDAQ: TGEN) named her replacement as CEO, Susan Robinson, to also fill Parker’s position on the board. Parker left the company she founded as a series of setbacks in the field of gene therapy put the company in a precarious position. Targeted Genetics stock closed Friday at 32 cents a share.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
